- Khan NH, Ahsan M, Taylor WD, Kogure K. Culturability and survival of marine, freshwater
and clinical Pseudomonas aeruginosa. Microbes Environ. 2010; 25(4): 266-274.
2. Tashiro Y, Yawata Y, Toyofuku M, Uchiyama H, Nomura N. Interspecies interaction between
Pseudomonas aeruginosa and other microorganisms. Microbes Environ. 2013; 28(1): 13-24.
3. Silby MW, Winstanley C, Godfrey SA, Levy SB, Jackson RW. Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev. 2011; 35(4): 652-680.
4. Rasamiravaka T, Labtani Q, Duez P, El Jaziri M. The formation of biofilms by Pseudomonas
aeruginosa: a review of the natural and synthetic compounds interfering with control
mechanisms. BioMed Res Int. 2015; 2015.
5. Lutz L, Pereira DC, Paiva RM, Zavascki AP, Barth AL. Macrolides decrease the minimal
inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from
cystic fibrosis patients in biofilm. BMC Microbiol. 2012; 12(1): 1.
6. Ghafoor A, Hay ID, Rehm BH. Role of exopolysaccharides in Pseudomonas aeruginosa
biofilm formation and architecture. Appl Environ Microbiol. 2011; 77(15): 5238-5246.
7. Wei Q, Ma LZ. Biofilm matrix and its regulation in Pseudomonas aeruginosa. Int J Mol Sci.
2013; 14(10): 20983-31005.
8. Wong TY, Preston LA, Schiller NL. Alginate lyase: review of major sources and enzyme
characteristics, structure-function analysis, biological roles, and applications. Annu Rev
Microbiol. 2000; 54(1): 289-340.
9. Shankar T, Sivakumar T, Satya C, Ponmanickam P. Purification, characterization and
immobilization of alginase produced by Bacillus sp associated with Sargassum wightii.
Universal J Microbiol Res. 2016; 4(1): 11-22.
10.Zhu B, Yin H. Alginate lyase: Review of major sources and classification, properties, structure
-function analysis and applications. Bioengineered. 2015; 6(3): 125-131.
11. Park HH, Kam N, Lee EY, Kim HS. Cloning and characterization of a novel oligoalginate
lyase from a newly isolated bacterium Sphingomonas sp. MJ-3. Mar Biotechnol. 2012; 14(2):
189-202.
12. Kim HS, Lee C-G, Lee EY. Alginate lyase: structure, property, and application. Biotechnol
Bioprocess Eng. 2011; 16(5): 843-851.
13. Ghadaksaz A, Fooladi AAI, Hosseini HM, Amin M. The prevalence of some Pseudomonas
virulence genes related to biofilm formation and alginate production among clinical isolates.
J Appl Biomed. 2015; 13(1): 61-68.
14. Preis J, Ashwell G. Alginic acid metabolism in bacteria. J Biol Chem. 1962; 237: 309-316.
15. English BK, Gaur AH. The use and abuse of antibiotics and the development of antibiotic
resistance. Hot Topics in Infection and Immunity in Children VI: Springer; 2010. p. 73-82.
16. Chatterjee M, Anju C, Biswas L, Kumar VA, Mohan CG, Biswas R. Antibiotic resistance in
Pseudomonas aeruginosa and alternative therapeutic options. Int J Med Microbiol. 2016; 306
(1): 48-58.
17. Tavafi H, Abdi-Ali AA, Ghadam P, Gharavi S. Screening of alginate lyase-producing bacteria
and optimization of media compositions for extracellular alginate lyase production. Iran
Biomed J. 2017; 21(1): 48.
18. Tavafi H, Ali AA, Ghadam P, Gharavi S. Screening, cloning and expression of a novel
alginate lyase gene from P. aeruginosa TAG 48 and its antibiofilm effects on P. aeruginosa
biofilm. Microb Pathog. 2018; 124: 356-364.
19. CLSI. Performance standards for antimicrobial susceptibility testing; 22nd Informational
Supplement. CLSI Document M100-S22. Clinical and Laboratory Standards Institute Wayne,
Pennsylvania; 2012.
20. Lorian V. Antibiotics in laboratory medicine: Lippincott Williams & Wilkins; 2005.
21. Sabaeifard P, Abdi-Ali A, Soudi MR, Dinarvand R. Optimization of tetrazolium salt assay for
Pseudomonas aeruginosa biofilm using microtiter plate method. J Microbiol Methods. 2014;
105: 134-140.
22. Shafiei M, Ali AA, Shahcheraghi F, Saboora A, Noghabi KA. Eradication of Pseudomonas
aeruginosa biofilms using the combination of n-butanolic cyclamen coum extract and
ciprofloxacin. Jundishapur J Microbiol. 2014; 7(2):e14358.
23. May TB, Shinabarger D, Maharaj R, Kato J, Chu L, DeVault JD. Alginate synthesis by
Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic
fibrosis patients. Clin Microbiol Rev. 1991; 4(2): 191-206.
24. Wozniak DJ, Wyckoff TJ, Starkey M, Keyser R, Azadi P, O'Toole GA. Alginate is not a
significant component of the extracellular polysaccharide matrix of PA14 and PAO1
Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci. 2003; 100(13): 7907-7912.
25. Dong S, Yang J, Zhang XY, Shi M, Song XY, Chen XL. Cultivable alginate lyase-excreting
bacteria associated with the arctic brown alga Laminaria. Mar Drugs. 2012; 10(11): 2481-2491.
26. Hatch RA, Schiller NL. Alginate lyase promotes diffusion of aminoglycosides through the
extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents
Chemother. 1998; 42(4): 974-977.
27. Eftekhar F, Speert DP. Alginase treatment of mucoid Pseudomonas aeruginosa enhances
phagocytosis by human monocyte-derived macrophages. Infect Immun. 1988; 56(11):
2788-2793.
28. Kaneko Y, Yonemoto Y, Okayama K, Kimura A, Murata K. Symbiotic formation of alginate
lyase in mixed culture of bacteria isolated from soil. J Biosci Bioeng. 1990; 69(3): 192-194.
29. May TB, Chakrabarty AM. Pseudomonas aeruginosa: genes and enzymes of alginate
synthesis. Trends Microbiol. 1994; 2(5): 151-157.
30. Kim DE, Lee EY, Kim HS. Cloning and characterization of alginate lyase from a marine
bacterium Streptomyces sp. ALG-5. Mar Biotechnol. 2009; 11(1): 10-16.
31. Thallinger B, Prasetyo EN, Nyanhongo GS, Guebitz GM. Antimicrobial enzymes: an
emerging strategy to fight microbes and microbial biofilms. Biotechnol. J. 2013; 8(1): 97-109.
32. Cotton LA, Graham RJ, Lee RJ. The role of alginate in P. aeruginosa PAO1 biofilm structural
resistance to gentamicin and ciprofloxacin. J Exp Microbiol Immunol. 2009; 13: 58-62.
33. Tseng BS, Zhang W, Harrison JJ, Quach TP, Song JL, Penterman J. The extracellular matrix
protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ
Microbiol. 2013; 15(10): 2865-2878.
|
